Central Nervous System Diseases  >>  memantine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
NCT01626391 / 2011-005292-17: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease

Terminated
2
9
Europe
TRx0237, Placebo
TauRx Therapeutics Ltd
Alzheimer's Disease
03/13
03/13
MAyflOwer RoAD, NCT01677754 / 2012-000943-29: A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy

Completed
2
542
US, Canada, Europe, RoW
RO4602522, Placebo, Donepezil, Memantine, Rivastigmine, Galantamine
Hoffmann-La Roche
Alzheimer's Disease
06/15
06/15
NCT02246075: Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine

Checkmark
Apr 2015 - Apr 2015: 
Withdrawn
2
0
US
EVP-6124, encenicline
FORUM Pharmaceuticals Inc, Quintiles, Inc.
Alzheimer's Disease, Dementia, Cognition
10/16
 

Download Options